Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Provenge is not approved for biochemically-recurrent prostate cancer. ... cancer immunotherapy, Provenge, was approved by the FDA in April 2010.
The UW Carbone Cancer Center is among several centers participating in a multi-site trial to test this immunotherapy, named CTL019, which was ...
Curious about what happens when you enroll in a cancer immunotherapy clinical trial? Hear first hand about one woman's experience as she dispels ...
Pancreatic disease successfully targeted with 'game-changing' drugs
Most pancreatic cancer sufferers succumb to it in weeks or months
But about one in six could be treated with drugs containing platinum
Breakthrough comes after researchers probed the DNA of tumours
The PD1-inhibitors make cancer cells more visible to the immune system, ... The vaccine is designed to trigger an immune system response against ...
"This deal strongly validates the importance of modulating the immune system in treating cancer, and more specifically brings attention to the ...
Dr. John Salerno discusses cancer and its relationship to insulin and nutrition. He says based on current data, most cancers are preventable. Find out how insulin and carbohydrates may play a big role!
The article titled "Pathology reporting of pancreatic cancer following neoadjuvant chemotherapy: Challenges and uncertainties" appeared in the ...
PharmaCyte's Proprietary Cell Technology to Create Insulin Producing Cells for Type 1 Diabetes - Diabetes News Journal
In the last few decades, little progress was made in improving outcomes for patients diagnosed with pancreatic cancer. The mortality of pancreatic ...
ABRAXANE® Now Reimbursed in Italy as a First-Line Treatment of Adult Patients with Metastatic ... -MarketWatch
A research team led by investigators from Mayo Clinic's campus in Jacksonville and the University of Oslo in Norway have identified a molecule that ...
Dr. Storz: Our study focuses on cellular signaling mechanisms that lead to the initiation of pancreatic cancer. After acquisition of an oncogenic mutation ...
Pancreatic cancer's lethal nature stems from its propensity to rapidly spread to distant organs. Because there is no early screening test, it usually is not ...
Business Line The fisherman from Odisha who was treated of pancreatic cancer with minimal invasive surgery by a team of doctors at the Global ...
Apart from metastatic pancreatic cancer, MM-398 is being evaluated for the treatment of colorectal cancer (phase II), glioma (phase I) and pediatric ...
There are just over 10,000 cases of bladder cancer diagnosed each year, according to figures from Cancer Research UK. It is 3–4 times more ...
New NICE guideline to ensure people with bladder cancer receive the same level of treatment and ... - NICE
(HealthDay News) -- Suicide is a public health concern for patients with genitourinary cancer, especially bladder cancer, according to a study ...
In Urologic Cancers, Suicide Deemed Public Health Concern - Cancer Therapy Advisor
Heat has two Phase II candidates for non-small cell lung cancer and nonmuscle invasive bladder cancer. Meanwhile, OncoSec is developing an ...
| Potential Therapeutic Target for Kidney Cancer Researchers have uncovered a novel way to potentially target clear cell renal cell carcinoma, a predominantly incurable disease for which patients have limited treatment options. |
| Sequential TKI May Benefit Advanced Renal Cell Carcinoma Patients According to a study by the Annals of Oncology, administering a sequential, second-line tyrosine kinase inhibitor (TKI) to patients with metastatic clear cell renal cell carcinoma (mccRCC), may be more beneficial over a mammalian target of rapamycin inhibitor (mTORi). |
| Overcoming Resistance in Prostate Cancer Researchers continue to look for ways to overcome resistance and identify new tumor targets. |
| XRCC2 Gene May Contribute to Testicular Cancer Treatment Resistance Scientists from The Institute of Cancer Research in London identified a gene which may contribute to testicular cancer treatment resistance. Learn more about it here. |
Order of Gene Mutations May Affect Outcomes in Myeloproliferative Neoplasms
New data indicates that the order in which people acquired certain somatic mutations influenced several clinical features of myeloproliferative neoplasms.
New data indicates that the order in which people acquired certain somatic mutations influenced several clinical features of myeloproliferative neoplasms.
Unlikelihood of Cure Did Not Reduce Chemo Use at End of Life
Patients with lung and colorectal cancers who understood that chemotherapy would not cure them were no less likely to receive chemotherapy at the end of life.
Patients with lung and colorectal cancers who understood that chemotherapy would not cure them were no less likely to receive chemotherapy at the end of life.
FDA Approves Front-Line Lenalidomide for Multiple Myeloma
The FDA has expanded the use of oral lenalidomide in multiple myeloma to include its use in combination with dexamethasone for newly diagnosed patients.
The FDA has expanded the use of oral lenalidomide in multiple myeloma to include its use in combination with dexamethasone for newly diagnosed patients.
R-CHOP Regimen Underused in Elderly DLBCL Patients
Despite an association with improved survival, elderly DLBCL patients are less likely to receive standard-of-care chemotherapy with R-CHOP.
Despite an association with improved survival, elderly DLBCL patients are less likely to receive standard-of-care chemotherapy with R-CHOP.
RT Effective for Palliation of Bone Metastases From HCC
A recent study found that radiation therapy was effective for the palliation of painful spinal metastases in patients with hepatocellular carcinoma.
A recent study found that radiation therapy was effective for the palliation of painful spinal metastases in patients with hepatocellular carcinoma.
Phone Counseling Improves QoL in Cervical Cancer Survivors
Cervical cancer survivors saw improvements in self-reported quality-of-life outcomes with a psychosocial telephone counseling intervention, according to a new study.
Cervical cancer survivors saw improvements in self-reported quality-of-life outcomes with a psychosocial telephone counseling intervention, according to a new study.
Science Daily Cancer News
A new compound developed at the University of Toronto Scarborough could play an important role in developing cheaper anti-cancer drugs.
Scientists have done the most in-depth analysis yet of 100 pancreatic cancer genomes and highlighted 4 subtypes that may help guide future patient treatment.
A new study shows that pediatric cancer patients who receive antibiotics within 60 minutes of reporting fever and showing neutropenia (low neutrophil count), go on to have decreased intensive care needs and lower mortality compared with patients who receive antibiotics outside the 60-minute window.
The biological mechanism that may give some cancer cells the ability to form tumors in dogs has been identified by researchers. The recent study uncovered an association between the increased expression of a particular gene in tumor cells and more aggressive behavior in a form of canine bone cancer. It may also have implications for human cancers by detailing a new pathway for tumor formation.
The complex parts of the blue light known as the Cherenkov Effect can be measured and used in dosimetry to make therapies safer and more effective, scientists report.
Treating patients with locally advanced inoperable breast cancer is an extremely difficult task. The overwhelming majority of patients treated for this disease suffer relapse and, despite the best multimodal treatment, do not survive. There is a medical need to examine current and potential treatments, researchers say in a new article.
Like a stealth jet cloaks itself from radar, cancer cells cloak themselves within tumors by hiding behind a dense layer of cellular material known as stroma. According to a new study, drugs that target and strip away the stroma would pave the way for drugs to reach the cancerous cells within the tumor, which could have a beneficial effect on the survival of pancreatic cancer patients.
Graphene has been used to target and neutralize cancer stem cells while not harming other cells, investigators report. This new development opens up the possibility of preventing or treating a broad range of cancers, using a non-toxic material, they say.
The most common type of ovarian cancer is more deadly if it consists of a patchwork of different groups of cells, according to a new study. Serous ovarian cancers containing a variety of genetically-different cells were more likely to become resistant to treatment and come back again than cancers made of more similar cells. Women with this type of tumor also died sooner than those with less varied tumors.
Tambahkan Komentar